Purchase Order 75N92025P00384
Award Date 9/19/25
Potential Completion Date 9/18/26
Potential Value $157K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
4
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institutes of Health (NIH) National Human Genome Research Institute (NHGRI) awarded a $119,200.00 firm fixed-price purchase order to Norgen Biotek Corp, a Canadian for-profit manufacturer, to provide exosome extraction services in support of future RNA sequencing work for NHGRI. This award is not associated with a set-aside program. Through previous federal contracts valued between $16,464 and $668,710, Norgen Biotek has provided similar exosome and extracellular RNA extraction,...
- The Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute (NHGRI) awarded a firm-fixed-price purchase order to Norgen Biotek Corp, a Canadian for-profit manufacturer, to provide exosome extraction services for future RNA sequencing. The potential value of the contract is $165,000.00, and the period of performance is from the award date of June 25, 2019, to the completion date of June 24, 2021. Norgen Biotek Corp has previously provided...
- This is a purchase order contract awarded by the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), to Norgen Biotek Corp, a Canadian for-profit manufacturer of biotechnology products and services. The contract, valued at $149,840, is for the provision of exosome and extracellular RNA extraction, isolation, purification, and sequencing services to support clinical research studies at NIH. Norgen Biotek has previously been awarded over $1 million in...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a firm fixed price purchase order valued at approximately $668,710 to Norgen Biotek Corp. of Ottawa, Canada. Under the terms of the contract, Norgen Biotek will extract and isolate intact RNA exosomes from plasma samples to support an unspecified clinical study being conducted by the National Heart, Lung and Blood Institute. The original solicitation sought proposals for...
- The U.S. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has awarded a $16,821.83 firm fixed-price purchase order to Norgen Biotek Corp, a Canadian for-profit manufacturer, to provide exosomal RNA purification services. This order, which does not have a set-aside designation, supports unspecified NIDDK and National Heart, Lung and Blood Institute clinical trials, as well as future RNA sequencing work for the National Human Genome Research Institute (NHGRI). Norgen Biotek...
- The National Human Genome Research Institute (NHGRI), a civilian agency within the National Institutes of Health (NIH), awarded a $11,508.00 firm fixed-price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract is for the procurement of 3 packs of 4 PROMETHION flow cell packs (RNA), with an ultimate completion date of August 7, 2024. This equipment supports NHGRI's ongoing genomics research initiatives, which utilize Oxford...
- The Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute awarded a $24,264 purchase order to Oxford Nanopore Technologies Inc. for the delivery of unspecified products or services. Performance will take place in New York, NY under a firm fixed price arrangement concluding on September 29, 2023. As the NIH/NHGRI supports genomic research to analyze DNA and interpret the book of life, this contract is likely to provide Oxford Nanopore's...
- This is a $37,814 firm fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Reprocell U.S.A., Inc. The contract is for the extraction of total RNA from whole blood samples in support of research activities at the National Human Genome Research Institute (NHGRI), another NIH agency. The contract was awarded on July 10, 2020 through full and open competition, with a period of performance ending on March 31,...
- The National Human Genome Research Institute (NHGRI), a civilian agency within the National Institutes of Health (NIH), awarded a $23,149 firm fixed price contract to 10X Genomics, Inc., a life sciences technology company in Pleasanton, California. The contract is for the provision of 10X MULTIOME LIBRARY REAGENTS required for research under Project Z01-HG000024, which focuses on the genetic analysis of type II diabetes in the Finnish population. This is a Blanket Purchase Agreement (BPA) call...
- <p>This is a firm fixed price purchase order contract awarded by the National Human Genome Research Institute (NHGRI), a civilian agency, to Invivogen, a for-profit organization, for the delivery of biological and reagent materials. The contract has a ceiling value of $12,992.70 and a period of performance ending on March 3, 2026. This contract is not associated with a larger vehicle and does not have a set-aside designation. The NHGRI is the funding agency for this contract.</p>